Agreement for Purchase of Regen BioPharma Series A Preferred Shares by Entest Biomedical, Inc. from Thomas E. Ichim
Entest Biomedical, Inc. and Thomas E. Ichim have agreed that Entest will purchase 3,500,000 Series A preferred shares of Regen BioPharma Inc. from Mr. Ichim. In exchange, Entest will pay $5,000 in cash and issue 500,000 of its own Series B preferred shares to Mr. Ichim. Mr. Ichim confirms that the shares are free of any legal claims and can be transferred. The agreement was signed on February 28, 2017.
Exhibit 10.2
Exhibit 10.2
ENTEST BIOMEDICAL,INC AND THOMAS E. ICHIM AGREEMENT
Entest Biomedical, Inc. agrees to purchase Regen BioPharma Inc.’s certificate #RA 576 for 3,500,000 series A preferred shares from Thomas E. Ichim ( owner) for the price of $5,000 cash and 500,000 Entest Biomedical, Inc. series B preferred shares.
Thomas E. Ichim acknowledges that his Regen Biophrama series A preferred shares are free of any encumbrances and able to be transferred to Entest Biomedical, Inc.
Signed in Agreement February 28, 2017
| /s/ David Koos | ||
| By: David Koos, CEO | ||
| ENTEST BIOMEDICAL, Inc. | ||
| /s/ Thomas E. Ichim | ||
| By: Thomas E. Ichim | ||
| Seller of Regen Biopharma | ||
| Series A Shares |
